{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:55:14Z","timestamp":1794639314839,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier","isbn-type":[{"value":"9780323853415","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.pbr.2020.07.008","type":"book-chapter","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T22:09:48Z","timestamp":1596665388000},"page":"155-166","source":"Crossref","is-referenced-by-count":13,"title":["Evidence on the neuroprotective properties of brimonidine in glaucoma"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pbr.2020.07.008_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bjo.88.1.88","article-title":"Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure","volume":"88","author":"Aung","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/tcrm.2006.2.4.337","article-title":"Brimonidine in the treatment of glaucoma and ocular hypertension","volume":"2","author":"Cantor","year":"2006","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0020","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3760\/cma.j.issn.0366-6999.20123565","article-title":"Neuroprotection in glaucoma: present and future","volume":"126","author":"Chen","year":"2013","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0022-3565(24)29683-X","article-title":"Alpha(2)-adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia","volume":"296","author":"Donello","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/2008-322X.183923","article-title":"Neuroprotection in glaucoma","volume":"11","author":"Doozandeh","year":"2016","journal-title":"J. Ophthalmic. Vis. Res."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0050","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/bjo.87.12.1463","article-title":"Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection","volume":"87","author":"Evans","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0039-6257(05)80042-6","article-title":"Mechanisms of optic nerve damage in primary open angle glaucoma","volume":"39","author":"Fechtner","year":"1994","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajo.2014.03.015","article-title":"Effect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma","volume":"158","author":"Feke","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the low-pressure glaucoma treatment study","volume":"151","author":"Krupin","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-6-4","article-title":"Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons","volume":"6","author":"Lambert","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1590\/S0004-27492011000200001","article-title":"Managing glaucoma in developing countries","volume":"74","author":"Leite","year":"2011","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0095","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1055\/s-0028-1111575","article-title":"Ophthalmological studies with dichlorophenylaminoimidazoline with special regard to its effect on intraocular pressure","volume":"91","author":"Makabe","year":"1966","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0100","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s10792-017-0768-z","article-title":"Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells","volume":"38","author":"Marangoz","year":"2018","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.397","article-title":"Non-amyloidogenic effects of alpha2 adrenergic agonists: implications for brimonidine-mediated neuroprotection","volume":"7","author":"Nizari","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0115","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/eye.2008.226","article-title":"Changes in visual function after intraocular pressure reduction using antiglaucoma medications","volume":"23","author":"Prata","year":"2009","journal-title":"Eye"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00055735-199704000-00008","article-title":"The role of alpha-agonists in glaucoma therapy","volume":"8","author":"Robin","year":"1997","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0125","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0161-6420(02)01900-0","article-title":"Dorzolamide\/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability","volume":"110","author":"Sall","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0130","doi-asserted-by":"crossref","unstructured":"Scuteri D, Rombol\u00e0 L, Watanabe C, Sakurada S, Corasaniti MT, Bagetta G, et al. 2020. Impact of nutraceuticals on glaucoma: a systematic review. Prog. Brain Res. (submitted).","DOI":"10.1016\/bs.pbr.2020.07.014"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0135","article-title":"Neuroprotection for treatment of glaucoma in adults","volume":"1","author":"Sena","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0140","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0145","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3129\/i07-045","article-title":"Glaucoma neuroprotection: what is it? why is it needed?","volume":"42","author":"Weinreb","year":"2007","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0155","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/bs.pbr.2020.07.008_bb0160","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archopht.117.11.1540","article-title":"Is neuroprotection a viable therapy for glaucoma?","volume":"117","author":"Weinreb","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0165","first-page":"321","article-title":"Comparison of latanoprost, brimonidine tartrate, and bimatoprost plus timolol maleate in fixed combinations","volume":"43","author":"Yava\u015f","year":"2013","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/bs.pbr.2020.07.008_bb0170","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/IJG.0000000000001285","article-title":"Effects of brimonidine and timolol on the progression of visual field defects in open-angle glaucoma: a single-center randomized trial","volume":"28","author":"Yokoyama","year":"2019","journal-title":"J. Glaucoma"}],"container-title":["Progress in Brain Research","Glaucoma: A Neurodegenerative Disease of the Retina and Beyond - Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612320301060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612320301060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T22:02:22Z","timestamp":1758751342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612320301060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780323853415"],"references-count":33,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2020.07.008","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}